Income StatementBalance SheetCash FlowSegments
Medtronic logo

Medtronic Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Medtronic holds $91.5B in total assets. Shareholders' equity is $49.0B against $28.1B in total debt. Cash and equivalents total $1.1B. The current ratio is 2.54 and debt-to-equity is 0.574. Based on the Q1 2026 filing.

Total Assets$91.5BTotal Stockholders Equity$49.0BLong Term Debt$27.9BCash And Equivalents$1.1BTotal Current Assets$24.1BTotal Current Liabilities$9.5B
Latest FilingQ1 2026
Report Date2026-02-24
Market Cap$99.3B
P/E Ratio21.52
ROE9.38%

Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts payable$2.4B$2.3B$2.4B$2.6B$2.6B$2.6B
Accrued compensation$1.9B$2.3B$2.5B$2.0B$2.1B$2.6B
Accrued Contingent Liabilities$200.0M$200.0M$400.0M$200.0M$200.0M$200.0M
Contract liabilities$467.0M$462.0M$446.0M$442.0M$451.0M$468.0M
Current portion of long-term debt$3.7B$2.6B$2.9B$2.4B$1.4B$191.0M
Deferred revenue$400.0M$400.0M—$400.0M$300.0M$400.0M
Derivative Liabilities Offset——$195.0M———
Derivative liabilities——$97.0M———
Finance Lease Liability, Current——$6.0M———
Income taxes payable$947.0M$1.1B$1.4B$933.0M$650.0M$650.0M
Note payable to DIRECTV$3.3B$3.5B$3.7B$3.6B$3.2B$3.5B
Other current liabilities———$1.2B$1.3B$1.3B
Total current liabilities$12.2B$11.8B$12.9B$11.5B$9.9B$9.5B

Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Accounts receivable, net$6.3B$6.1B$6.5B$6.3B$6.4B$6.4B
Available-for-Sale Debt Securities - Amortized Cost$6.7B$6.8B$6.8B$6.9B$7.0B$7.3B
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)$3.1B$3.3B$3.0B$2.4B$1.4B$1.9B
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)$782.0M$852.0M$814.0M$735.0M$760.0M$749.0M
Allowance for Doubtful Accounts Receivable (Current)$195.0M$204.0M$199.0M$204.0M$200.0M$207.0M
Cash and cash equivalents$1.4B$1.2B$2.2B$1.3B$1.3B$1.1B
Derivative Assets - Net Reduction from Master Netting Arrangements$107.0M$79.0M—$181.0M$186.0M$204.0M
Derivative assets$589.0M$980.0M$334.0M$335.0M$466.0M$536.0M
Trading assets$1.5B$1.6B—$1.4B$1.6B$1.5B
Finished goods$3.7B$3.7B$3.8B$4.0B$4.2B$4.2B
Raw materials$1.0B$1.1B$953.0M$1.1B$1.1B$1.2B
Work in process$728.0M$782.0M$744.0M$792.0M$853.0M$883.0M
Inventories$5.5B$5.6B$5.5B$5.9B$6.2B$6.3B
Net Cash Collateral Received - Derivative Instruments$52.0M$271.0M$125.0M———
Prepaid expenses and other current assets$2.7B$2.9B$2.9B$3.0B$3.1B$3.0B
Short-term investments$6.6B$6.7B$6.7B$6.8B$7.0B$7.2B
Total current assets$22.4B$22.5B$23.8B$23.2B$24.0B$24.1B

Equity

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Additional paid-in capital$20.8B$20.9B$20.8B$20.9B$20.9B$21.0B
Accumulated other comprehensive income (loss)-$3.3B-$2.8B-$4.3B-$4.6B-$4.3B-$4.3B
Common stock2.6B2.6B2.6B2.6B2.6B2.6B
Common Stock Par Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued1.3B1.3B1.3B1.3B1.3B1.3B
Noncontrolling interests$222.0M$228.0M$232.0M$240.0M$204.0M$211.0M
Retained earnings$30.9B$31.3B$31.5B$31.6B$32.1B$32.3B
Total liabilities and stockholders' equity$90.0B$90.0B$91.7B$91.0B$91.3B$91.5B
Total stockholders' equity$48.5B$49.4B$48.0B$47.9B$48.7B$49.0B
Unrealized Gains on Investments$22.0M$15.0M$26.0M$33.0M$72.0M$54.0M
Unrealized Losses on Investments (Before Tax)$138.0M$134.0M$100.0M$84.0M$57.0M$55.0M

Non-Current Assets

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Available-for-Sale Debt Securities - Fair Value (Maturing 1 to 5 Years)$3.3B$3.3B—$3.0B$2.9B$3.1B
Deferred tax assets$473.0M$452.0M$403.0M$416.0M$386.0M$365.0M
Equity method investments—$809.0M$705.0M$697.0M$671.0M$730.0M
Available-for-sale securities$3.2B$3.2B—$3.0B$2.9B$3.1B
Total investments—$311.0M$140.0M$50.0M$57.0M$50.0M
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)$1.5B$1.5B—$1.3B$1.3B$1.3B
Finite Lived Intangible Assets - Gross$28.9B$29.0B$28.9B$29.0B$29.0B$29.0B
Goodwill$41.2B$40.8B$41.7B$42.0B$41.8B$41.9B
Equity securities$311.0M$32.0M$140.0M$50.0M$57.0M$50.0M
Intangible assets, net$12.4B$12.2B$11.7B$11.2B$10.8B$10.3B
Other non-current assets$4.0B$4.3B$3.6B$3.6B$3.7B$4.0B
Accumulated depreciation$16.7B$17.1B$17.5B$18.0B$18.5B$18.9B
Property and equipment, net$6.4B$6.6B$6.8B$7.0B$7.2B$7.2B
Total assets$90.0B$90.0B$91.7B$91.0B$91.3B$91.5B

Non-Current Liabilities

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Debt Maturity - 5 to 10 Years$749.0M$778.0M—$1.1B$1.2B$1.2B
Debt Maturity - Over 10 Years$1.1B$1.2B—$1.3B$1.4B$1.4B
Debt - Unamortized Discount (Premium) and Issuance Costs, Net$125.0M$121.0M$117.0M$113.0M$122.0M$118.0M
Finance lease liabilities$50.0M$50.0M$52.0M$51.0M$55.0M$58.0M
Long-term debt$24.6B$24.0B$25.6B$26.2B$27.7B$27.9B
Other non-current liabilities$1.5B$1.5B$1.8B$1.8B$1.8B$1.8B
Total liabilities$41.3B$40.4B$43.4B$42.8B$42.5B$42.3B
Unrecognized Tax Benefits$2.9B$2.9B$2.9B$2.9B$2.9B$2.9B
Unrecognized Tax Benefits - Impacting Effective Tax Rate$2.7B$2.7B—$2.7B$2.7B$2.7B
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued$45.0M$63.0M$74.0M$99.0M$50.0M$36.0M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Fair Value Measurement Disclosure$110.0M$79.0M$417.0M$523.0M$349.0M$388.0M
Derivative Asset (Liability), Fair Value, Gross Asset (Liability)$479.0M$901.0M-$84.0M-$188.0M$117.0M$149.0M
Derivative Assets and Liabilities, Net, Collateral, Obligation to Return Cash$52.0M$271.0M-$125.0M-$194.0M-$87.0M-$115.0M
Derivative Assets and Liabilities, Net, Not Offset, Policy Election Deduction$0.0$0.0$0.0$0.0$0.0$0.0
Derivative, Fair Value, Amount Offset Against Collateral, Net$428.0M$629.0M$42.0M$6.0M$204.0M$264.0M
Equity Securities, FV-NI, Equity Securities Without Readily Determinable Fair Value, And Equity Method Investments—$1.2B$951.0M$850.0M$851.0M$1.0B
After-tax net unrealized gains (losses) associated with cash flow hedging instruments recorded in AOCI——-$149.0M-$276.0M-$108.0M-$116.0M
Remainder of Fiscal Year 2025$824.0M$414.0M—$1.3B$846.0M$405.0M